What is Royalty Pharma's total revenue?

Royalty Pharma (RPRX) reported total revenue of $630.58M in Q1 2026.

How has Royalty Pharma's total revenue changed year-over-year?

Royalty Pharma's total revenue increased by 11.0% year-over-year, from $568.25M to $630.58M.

What is the long-term trend for Royalty Pharma's total revenue?

Over 4 years (2021 to 2025), Royalty Pharma's total revenue has grown at a 1.0% compound annual growth rate (CAGR), from $2.29B to $2.38B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Royalty Pharma RPRX Total Revenue

Total Revenue at other companies

XOMA CorporationXOMA

$12.32M-22.6%

Ligand PharmaceuticalsLGND

$51.72M+14.1%

BridgeBio PharmaBBIO

$194.52M+66.8%

Rigel PharmaceuticalsRIGL

$58.82M+10.3%

Ionis PharmaceuticalsIONS

$246.09M+87.0%

ALN

Alnylam PharmaceuticalsALNY

$1.17B+96.4%

Other financials

Income statement

See full

Operating income$563.0M+5.4%

Net income$294.7M+23.1%

EPS (diluted)$0.67+21.8%

Balance sheet

See full

Cash & equivalents$586.4M-46.1%

Total debt$9.0B+17.8%

Total equity$9.9B+1.6%

Total assets$19.8B+12.5%

Cash flow

See full

Operating cash flow$718.2M+20.5%

Valuation

See full

Market cap$24.85B+72.3%

Enterprise value$33.24B+52.8%

P/E30×+15.9×

P/S10.2×+3.9×

Profitability

See full

Operating margin65.1%-18.9pp

Net margin33.9%-14.4pp

Returns & leverage

See full

Return on equity8.4%-2.7pp

Debt / equity0.9×+0.1×

Current ratio2.7×+1.1×

Where this comes from

Reported directly by Royalty Pharma in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Royalty Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Royalty Pharma's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Royalty Pharma's total revenue?: Royalty Pharma (RPRX) reported total revenue of $630.58M in Q1 2026.
How has Royalty Pharma's total revenue changed year-over-year?: Royalty Pharma's total revenue increased by 11.0% year-over-year, from $568.25M to $630.58M.
What is the long-term trend for Royalty Pharma's total revenue?: Over 4 years (2021 to 2025), Royalty Pharma's total revenue has grown at a 1.0% compound annual growth rate (CAGR), from $2.29B to $2.38B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.